Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Accord International Astrazeneca, Foxo Technologies, Getz Healthcare, Helius Medical, Histosonics, Igea Medical, Know Labs, Lunit, Surgibox.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Boston Scientific, Irhythm, Mursla, Nevro, Sequana, Vektor.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Brightheart, Philips, Roche, Zimmer Biomet.
Despite government efforts to prop up biopharma and med-tech research toward creating women’s health products, companies must eventually reach out to the private markets to bring their inventions to the next stage of development. Anna Zornosa-Heymann, a women’s health investor, serves as a part-time contractor with the U.S. NIH’s SEED (Small business Education & Entrepreneurial Development) office, where she helps companies move from government to external funding. Government funds are “excellent to pay for research … but those funds don’t allow you to build a first-class team and to develop a sales apparatus,” she told BioWorld.
Makers of devices and diagnostics face a new set of policy questions following the 2024 U.S. general elections, but many of the impending changes at the executive branch seem directed more toward drugs and vaccines, seemingly leaving the device and diagnostics industries largely out of harm’s way.
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alveo Technologies, Axonics, Boston Scientific, Caris, Cofactor Genomics, Exagen, Genomadix, Lumea, Myant, Nanoleq, Osmotex.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Omron, Medtronic.
RSS
